<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04578574</url>
  </required_header>
  <id_info>
    <org_study_id>20200841</org_study_id>
    <nct_id>NCT04578574</nct_id>
  </id_info>
  <brief_title>Effects of Bodily Illusion and tDCS on SCI-related Neuropathic Pain</brief_title>
  <official_title>Effects of Bodily Illusion and tDCS on Spinal Cord Injury (SCI) Related Neuropathic Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Florida</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effect of a combination of two procedures: (1)&#xD;
      Bodily Illusion (BI) and (2) Transcranial direct electrical stimulation (tDCS) on neuropathic&#xD;
      pain.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 13, 2021</start_date>
  <completion_date type="Anticipated">November 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in neuropathic pain severity</measure>
    <time_frame>baseline, up to two weeks</time_frame>
    <description>Assessed by the use of the Neuropathic Pain Symptom Inventory (NPSI). The NPSI has a total score ranging from 0 to 100 with the higher score indicating greater pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in performance of body part processing</measure>
    <time_frame>baseline, up to two weeks</time_frame>
    <description>Assessed by a customized computer task, where individual reaction times will be measured in response to mental rotation of body parts. Results will be reported in milliseconds.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in sensory thresholds</measure>
    <time_frame>baseline, up to two weeks</time_frame>
    <description>Assessed by the Quantitative Sensory Testing. Pain thresholds will be assessed using a numeric rating of 0 (No pain) to 10 (worse pain imaginable).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Neuropathic Pain</condition>
  <arm_group>
    <arm_group_label>BI-TDCS Stimulation Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group will receive the BI and TDCS interventions for 10 sessions over two weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BI-TDCS (Sham) Stimulation Group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Participants in this group will receive the BI and TDCS (Sham) interventions for 10 sessions over two weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bodily Illusions (BI) Procedure</intervention_name>
    <description>Each sessions will consists of two types of illusions that are 15 min each, the rubber hand illusion (RHI) and the walking illusion (WI) that involve both arms and legs.</description>
    <arm_group_label>BI-TDCS (Sham) Stimulation Group</arm_group_label>
    <arm_group_label>BI-TDCS Stimulation Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial direct electrical stimulation (tDCS)</intervention_name>
    <description>Each sessions will consists of electrical current delivered from a battery-driven, constant current stimulator using saline-soaked surface sponge electrodes. One electrode will be placed on your scalp on the right side and the other electrode over the left eye on your forehead. A weak current will be applied for 30 min at the same time as the BI.</description>
    <arm_group_label>BI-TDCS Stimulation Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham Transcranial Direct Electrical Stimulation (tDCS)</intervention_name>
    <description>Each session of the Sham tDCS will be applied for 30 min at the same time as the BI.</description>
    <arm_group_label>BI-TDCS (Sham) Stimulation Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Participants will be men or women, 18-70 years of age, with an incomplete cervical&#xD;
             traumatic SCI.&#xD;
&#xD;
          2. Participants must have experienced neuropathic pain for a minimum of six months. They&#xD;
             must have neuropathic pain in the moderate to severe category, which will be defined&#xD;
             as a score of at least 4 on a Numeric Rating Scale (NRS); (range of 0 to 10).&#xD;
&#xD;
          3. Participants must be willing and able to sign informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Major psychiatric disease/disorder (self-reported)&#xD;
&#xD;
          2. A significant neurological trauma besides SCI&#xD;
&#xD;
          3. A recent (one-year) history of alcohol or drug abuse (selfreported)&#xD;
&#xD;
          4. Any other medical conditions in which transcranial DCS is relatively contraindicated,&#xD;
             such as pregnancy, epilepsy and/or seizures&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eva Widerstrom-Noga, Phd</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roberta Vastano, Phd</last_name>
    <phone>305-243-7125</phone>
    <email>rxv331@med.miami.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberta Vastano</last_name>
      <phone>305-243-7125</phone>
      <email>rxv331@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Eva Widerstrom-Noga, Phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>October 2, 2020</study_first_submitted>
  <study_first_submitted_qc>October 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2020</study_first_posted>
  <last_update_submitted>June 16, 2021</last_update_submitted>
  <last_update_submitted_qc>June 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Eva Widerstrom-Noga</investigator_full_name>
    <investigator_title>Research Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuralgia</mesh_term>
    <mesh_term>Illusions</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

